hydroxide ion has been researched along with Tuberculosis in 1 studies
Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The anti-tuberculosis (anti-TB) drug pyrazinamide (PZA) was successfully intercalated into interlayer galleries of MgLH, resulting in the formation of the nanocomposite, PZA-MgLH, having an average size of about 107 ± 24 nm with a uniform circular shape." | 8.12 | Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug. ( Arulselvan, P; Bullo, N; El Zowalaty, ME; Fakurazi, S; Hussein, MZ; Saifullah, B; Webster, TJ, 2022) |
| " The anti-tuberculosis (anti-TB) drug pyrazinamide (PZA) was successfully intercalated into interlayer galleries of MgLH, resulting in the formation of the nanocomposite, PZA-MgLH, having an average size of about 107 ± 24 nm with a uniform circular shape." | 4.12 | Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug. ( Arulselvan, P; Bullo, N; El Zowalaty, ME; Fakurazi, S; Hussein, MZ; Saifullah, B; Webster, TJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saifullah, B | 1 |
| Arulselvan, P | 1 |
| Fakurazi, S | 1 |
| Webster, TJ | 1 |
| Bullo, N | 1 |
| Hussein, MZ | 1 |
| El Zowalaty, ME | 1 |
1 other study available for hydroxide ion and Tuberculosis
| Article | Year |
|---|---|
Development of a novel anti-tuberculosis nanodelivery formulation using magnesium layered hydroxide as the nanocarrier and pyrazinamide as a model drug.
Topics: Antitubercular Agents; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hyd | 2022 |